Colliton R P, Bason L, Lu F M, Piccoli D A, Krantz I D, Spinner N B
Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Hum Mutat. 2001 Feb;17(2):151-2. doi: 10.1002/1098-1004(200102)17:2<151::AID-HUMU8>3.0.CO;2-T.
Alagille syndrome (AGS) is an autosomal dominant disorder caused by mutations in Jagged1 (JAG1), a ligand in the evolutionarily conserved Notch signaling pathway. Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein truncating, splicing and missense mutations which are distributed across the coding region of the gene. Here we present results of JAG1 mutation screening by SSCP and FISH in 105 patients with AGS. For these studies, new primers were designed for 12 exons. Mutations were identified in 63/105 patients (60%). The spectrum of the JAG1 mutations presented here is consistent with previously reported results. Eighty three percent (52/63) of the mutations were protein truncating, 11% (7/63) were missense, 2% (1/63) were splice site, and 5% (3/63) were total gene deletions demonstrable by FISH. Six of the missense mutations are novel. As has been reported previously, there is no apparent relationship between genotype and clinical phenotype.
阿拉吉耶综合征(AGS)是一种常染色体显性疾病,由锯齿状蛋白1(JAG1)突变引起,JAG1是进化上保守的Notch信号通路中的一种配体。先前的研究表明,广泛的JAG1突变会导致AGS。这些突变包括全基因缺失、蛋白质截短、剪接和错义突变,它们分布在该基因的编码区域。在此,我们展示了对105例AGS患者进行单链构象多态性(SSCP)和荧光原位杂交(FISH)检测JAG1突变的结果。在这些研究中,针对12个外显子设计了新的引物。在105例患者中有63例(60%)检测到突变。此处呈现的JAG1突变谱与先前报道的结果一致。83%(52/63)的突变是蛋白质截短突变,11%(7/63)是错义突变,2%(1/63)是剪接位点突变,5%(3/63)是通过FISH检测到的全基因缺失。其中6个错义突变是新发现的。如先前报道的那样,基因型与临床表型之间没有明显关系。